Invus Public Equities, L.P. is > 10% Shareholder of Omega Therapeutics, Inc.. Currently has a direct ownership of 2.27 Million shares of OMGA, which is worth approximately $1.8 Million. The most recent transaction as insider was on Aug 03, 2021, when has been sold 1,323,530 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 2.27M
0% 3M change
0% 12M change
Total Value Held $1.8 Million

Invus Public Equities, L.P. Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 03 2021
BUY
Conversion of derivative security
-
1,323,530 Added 48.62%
1,398,530 Common Stock
Aug 03 2021
BUY
Open market or private purchase
$14,875,000 $17.0 p/Share
875,000 Added 27.79%
2,273,530 Common Stock
Jul 30 2021
BUY
Open market or private purchase
$1,210,500 $16.14 p/Share
75,000 Added 50.0%
75,000 Common Stock

Also insider at

SEER
Seer, Inc. Healthcare
GBIO
Generation Bio Co. Healthcare
LXRX
LEXICON PHARMACEUTICALS, INC. Healthcare
SRRK
Scholar Rock Holding Corp Healthcare
SQZ
SQZ Biotechnologies Co Healthcare
GLYC
GLYCOMIMETICS INC Healthcare
IPE

Invus Public Equities, L.P.

> 10% Shareholder
New York, NY

Track Institutional and Insider Activities on OMGA

Follow Omega Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells OMGA shares.

Notify only if

Insider Trading

Get notified when an Omega Therapeutics, Inc. insider buys or sells OMGA shares.

Notify only if

News

Receive news related to Omega Therapeutics, Inc.

Track Activities on OMGA